IP Library Granted Patent US 8,741,282
Granted Patent B2
US 8,741,282 · App. 12/140,544 · Granted Jun 3, 2014

Method for treatment of tendinosis with platelet rich plasma

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,741,282
App. No.
12/140,544
Granted
Jun 3, 2014
Kind
B2
Abstract

Methods are disclosed to promote vascularization of tissue in mammals using an autologous platelet-rich plasma composition. In particular, a method of treating a cardiac tissue lesion is disclosed.

Claims (10)

1. A method for treating tissue comprising:

identifying a lesion in need of treatment; and

treating the lesion by minimally invasively introducing a platelet composition into and around the lesion, wherein the lesion comprises a tendinosis and the platelet composition is introduced into and around the lesion, and wherein substantially no exogenous activator is administered to the lesion or added to the platelet composition prior to its introduction into and around the lesion, and wherein the platelet composition comprises a platelet rich plasma.

2. The method of claim 1 , wherein introducing the platelet composition comprises introducing three to five cubic centimeters of the platelet composition.

3. The method of claim 1 , wherein the pH of the platelet composition is between 7.35 and 8.0.

4. The method of claim 3 , further comprising buffering the platelet composition using a buffer selected from the group consisting of sodium bicarbonate, choline chloride, EGTA, HEPES, maleic acid, MOPS, PIPES, TES, TRIS BASE, TRIS-HCl, and urea.

5. The method of claim 1 , wherein the platelet rich plasma is autologous.

6. The method of claim 1 , wherein the platelet composition comprises an anti-coagulant.

7. The method of claim 6 , wherein the anti-coagulant comprises citrate-dextrose solution.

8. The method of claim 1 , further comprising introducing a composition comprising a local anesthetic agent into and around the lesion before administering the platelet composition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2021
From: MISHRA, ALLAN, DR.
To: BLUE ENGINE BIOLOGICS, LLC
Reel/Frame 056759/0943 →